CaaS Capital Management is a global investment firm with an emphasis on equity capital markets and liquidity provision. The firm invests across all regions, industries, and capital structures, employing a combined fundamental and quantitative approach to public and private equity.
65% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (50% of deals). Average disclosed round size is $107.0M (across 19 rounds with reported amounts).
Portfolio
16
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
FF
Frank Fu
Founder
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
20 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Umoja | Series C | $100M | Jan 2025 |
 Umoja Biopharma | Series C | $100M | Jan 2025 |
 HotSpot Therapeutics | Series C | $100M | Nov 2021 |
 T-Knife Therapeutics | Series B | $110M | Aug 2021 |
 Artios | Series C | $153M | Jul 2021 |
| AArtios Pharma Limited | Series C | $153M | Jul 2021 |
 Turnstone Biologics | Series D | $80M | Jul 2021 |
| Umoja | Series B | $210M | Jun 2021 |
 Stride Bio | Series B | $81.5M | Mar 2021 |
| SStrideBio | Series B | $81.5M | Mar 2021 |
 Amunix | Series B | $117M | Mar 2021 |
| AAmunix Pharmaceuticals | Series B | $117M | Mar 2021 |
 Cyteir Therapeutics | Series C | $80M | Feb 2021 |
| WWerewolf Therapeutics | Series B | $72M | Jan 2021 |
| AAmunix Pharmaceuticals | Series B | $117M | Jan 2021 |
| AArcellx, Inc. | Series C | $115M | Jan 2021 |
| TT-Knife | Series B | $110M | Jan 2021 |
 Rapid Micro Biosystems | Series A | $18.6M | Jan 2021 |
| Amunix | Series B | $117M | Jan 2021 |
| Artios | Series C | — | — |
Top Co-Investors
Avidity Partners8 shared
Omega Funds7 shared
Casdin Capital7 shared
RA Capital Management6 shared
Alexandria Venture Investments5 shared
Andera Partners5 shared
RTW Investments, LP5 shared
Soleus Capital5 shared
Venrock5 shared
Longitude Capital5 shared
Takeda Ventures, Inc.4 shared
Sofinnova Partners4 shared
Franklin Templeton4 shared
Viking Global Investors4 shared
Frazier Healthcare Partners4 shared
Polaris Partners4 shared
ArrowMark Partners4 shared
Redmile Group4 shared
MPM Capital4 shared
Last updated: 7 October 2026